World & BusinessNovo Nordisk plans more than five blockbuster drug launches by the end of the 2020s
Bloomberg reports that the Danish drugmaker is trying to stay competitive in an increasingly crowded obesity market, but its launch plans disappointed investors.
TLDR
Novo Nordisk plans to launch more than five blockbuster drugs by the end of the decade, Bloomberg reports. The company is trying to stay competitive in an increasingly crowded obesity market. Bloomberg says the planned launches disappointed investors.
Novo Nordisk plans more than five blockbuster drug launches by the end of the 2020s
Bloomberg reports that the Danish drugmaker is trying to stay competitive in an increasingly crowded obesity market, but its launch plans disappointed investors.
